Evidence map›Paper›PMID 20951945›Full record

ArticleCancer cell2010

T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation.

Hui Feng, David L Stachura, Richard M White, Alejandro Gutierrez, Lu Zhang, Takaomi Sanda, Cicely A Jette, Joseph R Testa, Donna S Neuberg, David M Langenau and 6 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cancer cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Zebrafish models of acute leukemias: Current models and future directions.Wiley interdisciplinary reviews. Developmental biology · 2021
    Review
  13. Article
  14. Article
  15. Disease models & mechanisms · 2020
    Article
  16. Zebrafish In Vivo Models of Cancer and Metastasis.Cold Spring Harbor perspectives in medicine · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. Pediatric mediastinal lymphoma.Mediastinum (Hong Kong, China) · 2020
    Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Hui FengDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
David L Stachura
Richard M White
Alejandro Gutierrez
Lu Zhang
Takaomi Sanda
Cicely A Jette
Joseph R Testa
Donna S Neuberg
David M Langenau
Jeffery L Kutok
Leonard I Zon
David Traver
Mark D Fleming
John P Kanki
A Thomas Look
Boston Children's Hospital · USDana-Farber Cancer Institute · USUniversity of California, San Diego · USBrigham and Women's Hospital · USFox Chase Cancer Center · USMassachusetts General Hospital · US

Funding

Zebrafish Screens for Genetic Modifiers and Human Application in T-ALLP01CA068484 · NCI · DANA-FARBER CANCER INSTITUTE · PI GELBER, RICHARD D · 1995 to 2010
$31.9M
Basis for Lymphomagenesis in Akt2 Transgenic MiceR01CA077429 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI TESTA, JOSEPH R. · 1998 to 2013
$4.7M
Blood Cells in Hemostasis and ThrombosisT32HL086344 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GINSBERG, MARK HOWARD · 2008 to 2023
$4.4M
Zebrafish Stem and Progenitor Cells and their Dysregulation in LeukemogenesisK01DK087814 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STACHURA, DAVID L · 2011 to 2015
$771k
Identification of self-renewal programs in muscle stem cellsK01AR055619 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2008 to 2012
$743k
"Oncorequisite" Genes in MYC-mediated TransformationR00CA134743 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FENG, HUI · 2012 to 2014
$712k
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALLK08CA133103 · NCI · DANA-FARBER CANCER INST · PI GUTIERREZ, ALEJANDRO · 2008 to 2012
$705k
Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2K01DK074555 · NIDDK · UNIVERSITY OF UTAH · PI JETTE, CICELY ANNE · 2006 to 2010
$666k
"Oncorequisite" Genes in MYC-mediated TransformationK99CA134743 · NCI · DANA-FARBER CANCER INST · PI FENG, HUI · 2009 to 2010
$282k
NCI NIH HHS 1K08CA133103NCI NIH HHS CA068484NCI NIH HHS CA077429NCI NIH HHS K08 CA133103NCI NIH HHS K99 CA134743NCI NIH HHS K99CA134743NCI NIH HHS L40 CA124083NCI NIH HHS P01 CA068484NCI NIH HHS R00 CA134743NCI NIH HHS R01 CA077429NHLBI NIH HHS T32 HL086344NHLBI NIH HHS T32-HL086344NIAMS NIH HHS 3K01AR055619-03S1NIAMS NIH HHS K01 AR055619NIAMS NIH HHS K01AR05562190-01A1NIDDK NIH HHS 1K01DK074555NIDDK NIH HHS K01 DK074555NIDDK NIH HHS K01 DK087814
6 · The paper itself

Abstract

The molecular events underlying the progression of T-lymphoblastic lymphoma (T-LBL) to acute T-lymphoblastic leukemia (T-ALL) remain elusive. In our zebrafish model, concomitant overexpression of bcl-2 with Myc accelerated T-LBL onset while inhibiting progression to T-ALL. The T-LBL cells failed to invade the vasculature and showed evidence of increased homotypic cell-cell adhesion and autophagy. Further analysis using clinical biopsy specimens revealed autophagy and increased levels of BCL2, S1P1, and ICAM1 in human T-LBL compared with T-ALL. Inhibition of S1P1 signaling in T-LBL cells led to decreased homotypic adhesion in vitro and increased tumor cell intravasation in vivo. Thus, blockade of intravasation and hematologic dissemination in T-LBL is due to elevated S1P1 signaling, increased expression of ICAM1, and augmented homotypic cell-cell adhesion.

Indexed as

AnimalsAnimals, Genetically ModifiedAutophagyBlood VesselsCell AggregationCell Line, TumorCell MovementDisease ProgressionEnzyme ActivationGene Expression Regulation, LeukemicHumansImmunohistochemistryIntercellular Adhesion Molecule-1Precursor T-Cell Lymphoblastic Leukemia-LymphomaProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2Intercellular Adhesion Molecule-1Proto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mycReceptors, Lysosphingolipid

Identifiers

PMID20951945
PMCPMC3003429
OpenAlexW2046371485

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.